Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.